New Top Exec Reshuffle To Steer OGT Down Dx Path
Executive Summary
Oxford Gene Technology has appointed its former head of R&D, John Anson, as CEO and brought in a new head of regulatory affairs, Paul Kenny, as the company shifts resources to the molecular diagnostics market.